Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

    Best Selling Products

    BioNewsCast Press Release Distribution Service

    BioNewsCast Press Release Distribution Service

     

    3rd Annual Stability Testing Conference

    3rd Annual Stability Testing Conference

     

    Next-Gen Sequencing Trends 2009

    Next-Gen Sequencing Trends 2009

     

    Competitor Analysis: c-MET/HGF Inhibitors

    Competitor Analysis: c-MET/HGF Inhibitors

     

    The Japanese Pharmaceutical Market 2008-2023

    The Japanese Pharmaceutical Market 2008-2023

     

    New Products

    Japanese Pharmaceutical Market 2009-2024

    Japanese Pharmaceutical Market 2009-2024

     

    3rd Annual Lyophilisation Conference

    3rd Annual Lyophilisation Conference

     

    The Global Bioinformatics Market: Market size, forecasts and company profiles

    The Global Bioinformatics Market: Market size, forecasts and company profiles

     

    Pharmaceutical Mergers and Acquisitions (PH133)

    Pharmaceutical Mergers and Acquisitions (PH133)

     

    Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

    Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

     

    Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

    Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

     

    The Global Analgesics Market 2009-2024

    The Global Analgesics Market 2009-2024

     

    Competitor Analysis: Coagulation Factors

    Competitor Analysis: Coagulation Factors

     

    Competitor Analysis: PDGF-R Agonists and Antagonists

    Competitor Analysis: PDGF-R Agonists and Antagonists

     

    World Market for Addiction Disorders, 2009-2016

    World Market for Addiction Disorders, 2009-2016

     

    BioPortfolio | Select Bioscience Reports |  Personalized Medicine Market Report 2007

    Personalized Medicine Market Report 2007

    Personalized Medicine Market Report 2007


    This report presents the latest industry analysis of the emerging field of Personalized Medicine. There is increasing interest in this field driven by the development of a number of molecular diagnostics-based tests that determine a patient’s genetic predisposition to a given disease—such as cancer, or to adverse drug reactions (ADRs).

    Personalized Medicine is growing rapidly—this report documents the various tests currently available, their market opportunity and hurdles to their market adoption. In addition, Select Biosciences presents in this report the current pipeline of personalized medicine-based tests in various different therapeutic areas.

    This report is the only report on the marketplace that presents a market analysis of the personalized medicine space based upon a proprietary market survey performed recently by Select Biosciences. The market analysis addresses qualitative market trends and quantitative market metrics, and pinpoints the opportunities and hurdles in this market.

    Topics Covered in this Report

    The Personalized Medicine Space

    Market Drivers

    CYP450 Polymorphisms and Drug Metabolism

    Personalized Medicine-based Tests on the Market Today

    Pipeline of Personalized Medicine-based Tests

    Regulatory Guidelines in the Personalized Medicine Space

    The Molecular Diagnostics Marketplace: Quantitative Metrics, Emerging Applications, and Market Trends—Personalized Medicine is a Fast-Growing Segment of Molecular Diagnostics

    Personalized Medicine Market Analysis: Qualitative and Quantitative Market Metrics based on Market Survey Data

    Company Profiles: Of the Relevant Market Participants

    Companies Profiled in this ReportAbbott Molecular/Vysis

    Affymetrix

    Agendia

    Celera Diagnostics

    Cepheid

    Clinical Data: PGxHealth and Cogenics

    Dakocytomation

    decode Genetics

    DNA Direct

    DxS Ltd

    Exact Sciences

    Exagen Diagnostics

    Gen-Probe

    Genelex

    Gene Logic

    Genentech

    Genomic Health, Inc.

    Genzyme Genetics

    Illumina

    Luminex/Tm Biosciences

    Monogram Biosciences

    Myriad Genetics

    Nanogen

    Osmetech plc

    Perlegen Sciences

    PGxI Laboratories

    Prometheus Laboratories

    Roche Diagnostics

    Siemens Medical Solutions Diagnostics

    Target Discovery

    Third Wave Technologies

    XDx

    Ventana Medical Systems

    Published: April 2007

    Pages: 104

    PDF Format
    Table of Contents

    Price
    Single User Print Version $3538.00   
    Electronic Site License (pdf + one print copy) $4175.00   



    BioPortfolio uses RBS Worldpay Secure Server for credit card transactions